drugset / Trial / NCT02131220

Effects of Intracoronary Prourokinase on the Coronary Flow During Primary Percutaneous Coronary Intervention for Acute Myocardial Infarction

NCT02131220

Phase 4 Completed 362 enrolled Fudan University
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to determine whether intracoronary selective thrombolysis are more effective than tirofiban on the coronary flow during primary percutaneous coronary intervention for the acute myocardial infarction.

Timeline

Start
2015-11
Primary completion
2017-08
Completion
2017-09

Drugs

EvaluationDrugModalityDoseRoute
Comparator Tirofiban Other / unclassified 10 ug/kg Other
Subject prourokinase Protein / enzyme biologic 20 mg Other

Indications